Amplifying Evidence With Unified Clinical Trial Data Collection

The dearth of robust evidence in clinical research often results in healthcare providers making prescribing decisions devoid of randomized, double-blind clinical trials' support, contributing to prolonged drug development timelines and exorbitant costs averaging $3 billion over 12 years.

In this presentation, we explore the transformative potential of integrating a unified clinical trial data collection platform with intelligent automation, challenging the inadequacies of the current status quo. With cutting-edge capabilities, the industry can now contemplate novel approaches, such as integrating additional sensors to discern surrogate or alternative endpoints, reevaluating adaptive trial designs, and swiftly adapting to emerging data trends.